Matrix GLA protein stimulates VEGF expression through increased transforming growth factor-beta1 activity in endothelial cells

• Published in: The Journal of biological chemistry Vol. 279; no. 51; pp. 52904 - 52913
• Main Authors: Boström, Kristina, Zebboudj, Amina F, Yao, Yucheng, Lin, Than S, Torres, Alejandra
• Format: Journal Article
• Language: English
• Published: United States 17.12.2004
• Subjects: Animals; Aorta - pathology; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins - metabolism; Bos; Calcium-Binding Proteins - metabolism; Calcium-Binding Proteins - physiology; Cattle; Cell Movement; Cell Proliferation; Cells, Cultured; Collagen - chemistry; Dose-Response Relationship, Drug; Drug Combinations; Endothelial Cells - metabolism; Extracellular Matrix Proteins - metabolism; Extracellular Matrix Proteins - physiology; Fibroblast Growth Factor 2 - metabolism; Genes, Reporter; Humans; Immunoblotting; Immunoprecipitation; Laminin - chemistry; Luciferases - metabolism; Matrix Gla Protein; Plasmids - metabolism; Proteoglycans - chemistry; Reverse Transcriptase Polymerase Chain Reaction; RNA - chemistry; RNA - metabolism; Time Factors; Transfection; Transforming Growth Factor beta - metabolism; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A - metabolism
• ISSN: 0021-9258; 1083-351X

Matrix GLA protein (MGP) is expressed in endothelial cells (EC), and MGP deficiency results in developmental defects suggesting involvement in EC function. To determine the role of MGP in EC, we cultured bovine aortic EC with increasing concentrations of human MGP (hMGP) for 24 h. The results showed increased proliferation, migration, tube formation, and increased release of vascular endothelial growth factor-A (VEGF-A) and basic fibroblast growth factor (bFGF). HMGP, added endogenously or transiently expressed, increased VEGF gene expression dose-dependently as determined by real-time PCR. To determine the mechanism by which hMGP increased VEGF expression, we studied the effect of MGP on the activity of transforming growth factor (TGF)-beta1 compared with that of bone morphogenetic protein (BMP)-2 using transfection assays with TGF-beta- and BMP-response element reporter genes. Our results showed a strong enhancement of TGF-beta1 activity by hMGP, which was paralleled by increased VEGF expression. BMP-2 activity, on the other hand, was inhibited by hMGP. Neutralizing antibodies to TGF-beta blocked the effect of MGP on VEGF expression. The enhanced TGF-beta1 activity specifically activated the Smad1/5 pathway indicating that the TGF-beta receptor activin-like kinase 1 (ALK1) had been stimulated. It occurred without changes in expression of TGF-beta1 or ALK1 and was mimicked by transfection of constitutively active ALK1, which increased VEGF expression. Expression of VEGF and MGP was induced by TGF-beta1, but the induction of MGP preceded that of VEGF, consistent with a promoting effect on VEGF expression. Together, the results suggest that MGP plays a role in EC function, altering the response to TGF-beta superfamily growth factors.